Track Bajaj Healthcare Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 1.69 %
Low
323.4
High
340.9
1 Month returns: -2.45 %
Low
313.4
High
394.8
1 Year returns: -27.14 %
Low
272.4
High
516.2
3 Year CAGR: -0.61 %
Low
263.3
High
745.0
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Bajaj Healthcare Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Bajaj Healthcare Ltd. Shareholding Pattern
Quarterly breakdown of Bajaj Healthcare Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Bajaj Healthcare Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Bajaj Healthcare Ltd.?
The current share price of Bajaj Healthcare Ltd. is ₹ 334.75 as of 13 Aug 2026.
What is the market capitalisation of Bajaj Healthcare Ltd.?
The market capitalisation of Bajaj Healthcare Ltd. stands at ₹ 1,100.44 Cr.
What is the PE ratio of Bajaj Healthcare Ltd.?
The Price-to-Earnings (PE) ratio of Bajaj Healthcare Ltd. is 62.42 as of the latest trailing twelve months data.
What is the ROE and ROCE of Bajaj Healthcare Ltd.?
Bajaj Healthcare Ltd. has a Return on Equity (ROE) of 3.16% and a Return on Capital Employed (ROCE) of 10.50% as per the latest financial reports.
What is the 52-week high and low of Bajaj Healthcare Ltd.?
The 52-week high of Bajaj Healthcare Ltd. is - and the 52-week low is -.
What is the dividend yield of Bajaj Healthcare Ltd.?
The dividend yield of Bajaj Healthcare Ltd. is 0.46% based on the current market price.
What is the FII and DII holding in Bajaj Healthcare Ltd.?
Foreign Institutional Investors (FII) hold 2.19%, Domestic Institutional Investors (DII) hold 1.69% and retail/public investors hold 33.63% of Bajaj Healthcare Ltd. shares.
What sector does Bajaj Healthcare Ltd. belong to?
Bajaj Healthcare Ltd. operates in the Healthcare sector.
What is the beta of Bajaj Healthcare Ltd.?
The beta of Bajaj Healthcare Ltd. is 1.03, indicating its price volatility relative to the broader market. Over the past 1 year, Bajaj Healthcare Ltd. has delivered an absolute return of -31.15%.
What is the RSI of Bajaj Healthcare Ltd.?
The 14-day Relative Strength Index (RSI) of Bajaj Healthcare Ltd. is 46.05, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Bajaj Healthcare Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Moderate operating margin but improving trend
The company reported moderate operating margin of 12.76% for 12-month ended 30 Jun 2026 but operating margin improved by 281 bps from 1 year ago
What is Operating profit margin?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.47 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 6 financial years
What is Dividend streak?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 62.42 indicates that the stock is expensive on a standalone basis and is at a 110.88% premium to industry median P/E
What is P/E Ratio?
Median: 29.6
Value 62.42
0.33286.35
Weak price momentum
Price Momentum score of 23.3 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
23.3 / 100
Low and declining ROE
The company reported low ROE of 3.16% for 12-month ended 30 Jun 2026 and ROE declined by -744 bps from 1 year ago
What is ROE (FY)?
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -53.41% for 12-month ended 30 Jun 2026 and the growth was 63.16 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Low dividend yield
The company has a low dividend yield of 0.46%
What is Dividend yield?
Neutral
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 12.27% for 12-month ended 30 Jun 2026 and the growth was 0.69 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 11.58
Value 12.27
-42.894040.18
Company's earnings are of moderate quality
Earnings quality score of 68.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
68.7 / 100
No red flags found!
No significant red flags found in the stock.
Company Profile
Overview of Bajaj Healthcare Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. It operates through three segments: APIs, Finished Dosage Formulations (FDFs), and Intermediates. Its APIs include Ascorbic Acid IP, Sodium Ascorbate, Ferrous Ascorbate, and others. Its Intermediary products include Calcium Phosphoryl Choline Chloride (CPCC) and Chlorhexidine (CH Base). It offers a range of FDFs forms, including tablets, caplets, capsules, and oral powders, all available in bulk quantities. The FDFs products include Cholecalciferol Sachet, Ticagrelor Tablet, Pancreatin Capsules, levofloxacin Tablets IP, Bisacodyl Tablet IP, and others.
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. It is focused on development, manufacturing...
Key personnel
Rohan Parekh
Chief Financial Officer
Monica Tanwar
Company Secretary and Compliance Officer
Mr. Sajankumar R. BajajD
Chairman of the Board, Managing Director, Executive Director